Interleukin-23 facilitates thyroid cancer cell migration and invasion by inhibiting SOCS4 expression via MicroRNA-25

PLoS ONE

Volumn 10, Issue 10, 2015, Pages

  Mei, Zhidan ^a   Chen, Shiming ^a   Chen, Chen ^a   Xiao, Bokui ^a   Li, Fen ^a   Wang, Yongping ^a   Tao, Zezhang ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 23; MICRORNA; MICRORNA 25; SOCS4 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; DNA; MIRN25 MICRORNA, HUMAN; SMALL INTERFERING RNA; SOCS4 PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ARTICLE; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRACELLULAR SIGNALING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN RNA BINDING; THYROID CANCER CELL LINE; ADULT; BIOSYNTHESIS; CELL MOTION; DRUG EFFECTS; FEMALE; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; THYROID TUMOR; TUMOR CELL CULTURE; TUMOR INVASION; UPREGULATION;

3' UNTRANSLATED REGIONS; ADULT; CELL MOVEMENT; DNA, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKIN-23; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM INVASIVENESS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; THYROID NEOPLASMS; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 84947205751     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0139456     Document Type: Article

References (33)

1. Chen AY, Jemal A, Ward EM (2009) Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer 115: 3801-3807. doi: 10.1002/cncr.24416 PMID: 19598221
2. Davies L, Welch HG (2006) Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 295: 2164-2167. PMID: 16684987
3. Schreiber RD, Old LJ, Smyth MJ (2011) Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science 331: 1565-1570. doi: 10.1126/science.1203486 PMID: 21436444
4. Yu H, Kortylewski M, Pardoll D (2007) Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment. Nat Rev Immunol 7: 41-51. PMID: 17186030
5. Chen D, Jiang R, Mao C, Shi L, Wang S, Yu L, et al. (2012) Chemokine/chemokine receptor interactions contribute to the accumulation of Th17 cells in patients with esophageal squamous cell carcinoma. Hum Immunol 73: 1068-1072. doi: 10.1016/j.humimm.2012.07.333 PMID: 22863447
6. Oppmann B, Lesley R, Blom B, Timans JC, Xu Y, Hunte B, et al. (2000) Novel p19 protein engages IL- 12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13: 715-725. PMID: 11114383
7. Chen D, Li W, Liu S, Su Y, Han G, Xu C, et al. (2015) Interleukin-23 promotes the epithelial-mesenchymal transition of oesophageal carcinoma cells via the Wnt/beta-catenin pathway. Sci Rep 5: 8604. doi: 10.1038/srep08604 PMID: 25721268
8. Klein A, Schwartz H, Sagi-Assif O, Meshel T, Izraely S, Ben Menachem S, et al. (2015) Astrocytes facilitate melanoma brain metastasis via secretion of IL-23. J Pathol.
9. Li J, Lau G, Chen L, Yuan YF, Huang J, Luk JM, et al. (2012) Interleukin 23 promotes hepatocellular carcinoma metastasis via NF-kappa B induced matrix metalloproteinase 9 expression. PLoS One 7: e46264. doi: 10.1371/journal.pone.0046264 PMID: 23050001
10. Suzuki H, Ogawa H, Miura K, Haneda S, Watanabe K, Ohnuma S, et al. (2012) IL-23 directly enhances the proliferative and invasive activities of colorectal carcinoma. Oncol Lett 4: 199-204. PMID: 22844353
11. Hilton DJ (1999) Negative regulators of cytokine signal transduction. Cell Mol Life Sci 55: 1568-1577. PMID: 10526574
12. Ram PA, Waxman DJ (1999) SOCS/CIS protein inhibition of growth hormone-stimulated STAT5 signaling by multiple mechanisms. J Biol Chem 274: 35553-35561. PMID: 10585430
13. Fujitake S, Hibi K, Okochi O, Kodera Y, Ito K, Akiyama S, et al. (2004) Aberrant methylation of SOCS-1 was observed in younger colorectal cancer patients. J Gastroenterol 39: 120-124. PMID: 15074307
14. To KF, Chan MW, Leung WK, Ng EK, Yu J, Bai AH, et al. (2004) Constitutional activation of IL-6-mediated JAK/STAT pathway through hypermethylation of SOCS-1 in human gastric cancer cell line. Br J Cancer 91: 1335-1341. PMID: 15354212
15. He B, You L, Uematsu K, Zang K, Xu Z, Lee AY, et al. (2003) SOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer. Proc Natl Acad Sci U S A 100: 14133-14138. PMID: 14617776
16. Weber A, Hengge UR, Bardenheuer W, Tischoff I, Sommerer F, Markwarth A, et al. (2005) SOCS-3 is frequently methylated in head and neck squamous cell carcinoma and its precursor lesions and causes growth inhibition. Oncogene 24: 6699-6708. PMID: 16007169
17. Lai RH, Hsiao YW, Wang MJ, Lin HY, Wu CW, Chi CW, et al. (2010) SOCS6, down-regulated in gastric cancer, inhibits cell proliferation and colony formation. Cancer Lett 288: 75-85. doi: 10.1016/j.canlet. 2009.06.025 PMID: 19646809
18. Storojeva I, Boulay JL, Ballabeni P, Buess M, Terracciano L, Laffer U, et al. (2005) Prognostic and predictive relevance of DNAM-1, SOCS6 and CADH-7 genes on chromosome 18q in colorectal cancer. Oncology 68: 246-255. PMID: 16015041
19. Lewis BP, Burge CB, Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20. PMID: 15652477
20. Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136: 215-233. doi: 10.1016/j.cell.2009.01.002 PMID: 19167326
21. Zhang B, Pan X, Cobb GP, Anderson TA (2007) microRNAs as oncogenes and tumor suppressors. Dev Biol 302: 1-12. PMID: 16989803
22. Petrocca F, Vecchione A, Croce CM (2008) Emerging role of miR-106b-25/miR-17-92 clusters in the control of transforming growth factor beta signaling. Cancer Res 68: 8191-8194. doi: 10.1158/0008-5472.CAN-08-1768 PMID: 18922889
23. Feng S, Pan W, Jin Y, Zheng J (2014) MiR-25 promotes ovarian cancer proliferation and motility by targeting LATS2. Tumour Biol 35: 12339-12344. doi: 10.1007/s13277-014-2546-0 PMID: 25179841
24. Li Q, Zou C, Zou C, Han Z, Xiao H, Wei H, et al. (2013) MicroRNA-25 functions as a potential tumor suppressor in colon cancer by targeting Smad7. Cancer Lett 335: 168-174. doi: 10.1016/j.canlet.2013. 02.029 PMID: 23435373
25. Yang T, Chen T, Li Y, Gao L, Zhang S, Wang T, et al. (2015) Downregulation of miR-25 modulates non-small cell lung cancer cells by targeting CDC42. Tumour Biol 36: 1903-1911. doi: 10.1007/s13277-014-2793-0 PMID: 25432132
26. Zhao H, Wang Y, Yang L, Jiang R, Li W (2014) MiR-25 promotes gastric cancer cells growth and motility by targeting RECK. Mol Cell Biochem 385: 207-213. PMID: 24078004
27. Li J, Lau GK, Chen L, Dong SS, Lan HY, Huang XR, et al. (2011) Interleukin 17A promotes hepatocellular carcinoma metastasis via NF-kB induced matrix metalloproteinases 2 and 9 expression. PLoS One 6: e21816. doi: 10.1371/journal.pone.0021816 PMID: 21760911
28. Xiong T, Li Y, Li Z, Xie X, Lu L (2013) In vivo monitoring the process of tumor growth, metastasis and bacterial infection expressing GFP via real-time optical imaging. J Biomed Nanotechnol 9: 274-280. PMID: 23627054
29. Spano D, Zollo M (2012) Tumor microenvironment: a main actor in the metastasis process. Clin Exp Metastasis 29: 381-395. doi: 10.1007/s10585-012-9457-5 PMID: 22322279
30. Li J, Zhang L, Zhang J, Wei Y, Li K, Huang L, et al. (2013) Interleukin 23 regulates proliferation of lung cancer cells in a concentration-dependent way in association with the interleukin-23 receptor. Carcinogenesis 34: 658-666. doi: 10.1093/carcin/bgs384 PMID: 23250909
31. Kobayashi D, Nomoto S, Kodera Y, Fujiwara M, Koike M, Nakayama G, et al. (2012) Suppressor of cytokine signaling 4 detected as a novel gastric cancer suppressor gene using double combination array analysis. World J Surg 36: 362-372. doi: 10.1007/s00268-011-1358-2 PMID: 22127425
32. Sasi W, Jiang WG, Sharma A, Mokbel K (2010) Higher expression levels of SOCS 1,3,4,7 are associated with earlier tumour stage and better clinical outcome in human breast cancer. BMC Cancer 10: 178. doi: 10.1186/1471-2407-10-178 PMID: 20433750
33. Sutherland KD, Lindeman GJ, Choong DY, Wittlin S, Brentzell L, Phillips W, et al. (2004) Differential hypermethylation of SOCS genes in ovarian and breast carcinomas. Oncogene 23: 7726-7733. PMID: 15361843